Not Applicable
Not Applicable
Not Applicable
Not Applicable
Not Applicable
The disclosure and prior art relates to tissue box devices and more particularly pertains to a new tissue box device for defining a vertically collapsible tissue box.
An embodiment of the disclosure meets the needs presented above by generally comprising a panel that has a plurality of fold lines thereon thereby facilitating the panel to be formed into a tissue box. The panel has a pair of tear away elements thereon that collectively define an upper half and a lower half of the tissue box. Each of the tear away elements is removable from the tissue box. In this way the upper half can to be lowered around the lower half to enhance access to tissues in the lower half of the tissue box.
There has thus been outlined, rather broadly, the more important features of the disclosure in order that the detailed description thereof that follows may be better understood, and in order that the present contribution to the art may be better appreciated. There are additional features of the disclosure that will be described hereinafter and which will form the subject matter of the claims appended hereto.
The objects of the disclosure, along with the various features of novelty which characterize the disclosure, are pointed out with particularity in the claims annexed to and forming a part of this disclosure.
The disclosure will be better understood and objects other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such description makes reference to the annexed drawings wherein:
With reference now to the drawings, and in particular to
As best illustrated in
The panel 12 has a first surface 24, a second surface 26 and a perimeter edge 28 extending therebetween. The perimeter edge 28 has a front side 30, a back side 32, a first lateral side 34 and a second lateral side 36. Each of the fold lines 14 extends between the front side 30 and the back side 32, and the fold lines 14 are spaced apart from each other and are distributed between the first 34 and second 36 lateral sides. The fold lines 14 define a primary flap 38 that is coextensive with the second lateral side 36. The fold lines 14 define a first lateral portion 40 of the tissue box 16 extending from the primary flap 38 toward the first lateral side 34.
The fold lines 14 define a top portion 42 of the tissue box 16 extending from the first lateral portion 40 toward the first lateral side 34. Additionally, the fold lines 14 define a second lateral portion 44 of the tissue box 16 extending from the top portion 42 toward the first lateral side 34. The fold lines 14 define a bottom portion 46 of the tissue box 16 extending between the second lateral portion 44 and the first lateral side 34. Each of the tear away elements 18 extends between the front 30 and back 32 sides and each of the tear away elements 18 is centrally positioned on a respective one of the first 40 and second 44 lateral portions of the tissue box 16. Additionally, each of the tear away elements 18 comprises a strip 48 that is defined by perforations 50 that extending through the respective first 40 and second 44 lateral portions of the tissue box 16.
The panel 12 has a plurality of first cuts 52 each extending from the front side 30 toward the back side 32. Moreover, each of the first cuts 52 is aligned with a respective one of the fold lines 14 and a respective one of the tear away elements 18. Each of the first cuts 52 defines a respective one of a plurality of first flaps 54. The panel 12 has a plurality of second cuts 56 each extending from the back side 32 toward the front side 30. Additionally, each of the second cuts 56 is aligned with a respective one of the fold lines 14 and a respective one of the tear away elements 18. Each of the second cuts 56 defines a respective one of a plurality of second flaps 58 and each of the second flaps 58 is aligned with a respective one of the first flaps 54.
The panel 12 has a slot 60 extending through the first 24 and second 26 surfaces and the slot 60 is centrally positioned on the top portion 42 of the tissue box 16. Moreover, the slot 60 facilitates access to the tissues that are positioned in the tissue box 16. The slot 60 is oriented to extend along a line that extends between the front 30 and back 32 sides of the perimeter edge 28 of the panel 12 and the slot 60 has a bounding edge 62. A membrane 64 is coupled to the bounding edge 62 of the slot 60 such that the membrane 64 covers the slot 60. The membrane 64 has a slit 66 therein thereby facilitating the tissues contained in the tissue box 16 to be drawn through the slit 66.
In use, the panel 12 is folded along each of the fold lines 14 to define the tissue box 16. Each of the first 54 and second 58 flaps is folded inwardly when panel 12 is folded along the fold lines 14. In this way the tissue box 16 is formed for containing tissues. Each of the tear away elements 18 is torn away from the tissue box 16 when the tissues in the tissue box 16 become depleted to the point that the tissues cannot be accessed through the slot 60. Thus, the upper half 20 of the tissue box 16 can be lowered around the lower half 22 of the tissue box 16. In this way the slot 60 is positioned closer to the tissues in the lower half 22 of the tissue box 16 the enhance accessing the tissues in the lower half 22 of the tissue box 16.
With respect to the above description then, it is to be realized that the optimum dimensional relationships for the parts of an embodiment enabled by the disclosure, to include variations in size, materials, shape, form, function and manner of operation, assembly and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by an embodiment of the disclosure.
Therefore, the foregoing is considered as illustrative only of the principles of the disclosure. Further, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the disclosure to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the disclosure. In this patent document, the word “comprising” is used in its non-limiting sense to mean that items following the word are included, but items not specifically mentioned are not excluded. A reference to an element by the indefinite article “a” does not exclude the possibility that more than one of the element is present, unless the context clearly requires that there be only one of the elements.
Number | Name | Date | Kind |
---|---|---|---|
3224633 | Dayton | Dec 1965 | A |
5065936 | King | Nov 1991 | A |
7172093 | Bando | Feb 2007 | B2 |
20050150801 | Tippey | Jul 2005 | A1 |
20050173269 | Lebras | Aug 2005 | A1 |
20070194035 | Kivatisky | Aug 2007 | A1 |
20170175336 | Hirata | Jun 2017 | A1 |
Number | Date | Country | |
---|---|---|---|
20200346815 A1 | Nov 2020 | US |